Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion

Overview of attention for article published in Journal of Translational Medicine, November 2012

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 792 followers.

Safety profile and pharmacokinetic analyses of the anti-CTLA4 antibody tremelimumab administered as a one hour infusion https://t.co/iVO9UdTF8S

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.